GO:0072205 metanephric collecting duct development: Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072205 describes the developmental progression of the collecting duct in the metanephros, from its formation to the mature structure that responds to vasopressin and aldosterone.
• The collecting duct is the final common path for urine before it enters the ureter and bladder, making its development essential for water, electrolyte, and acid-base balance.
• Ureteric bud branching and collecting duct morphogenesis are driven by reciprocal inductive signals between the metanephric mesenchyme and the ureteric bud epithelium.
• Human pluripotent stem cell-derived ureteric bud and collecting duct organoids now provide tractable models to study this process in vitro.
• p53 and developmental hypoxia are among the regulators that influence metanephric development and collecting duct maturation.
• Disrupted collecting duct development is linked to congenital anomalies of the kidney and urinary tract, including ureteropelvic junction obstruction.
Description
The metanephric collecting duct is the terminal segment of the nephron and the final common pathway for urine before it enters the ureter and bladder. Its development, annotated as GO:0072205 metanephric collecting duct development, encompasses the progression of this duct in the metanephros from its formation to a mature structure capable of responding to vasopressin and aldosterone to regulate water, electrolyte, and acid-base balance. Understanding this process is central to kidney developmental biology and to interpreting congenital and acquired renal disease. The collecting duct system arises from the ureteric bud, which invades the metanephric mesenchyme and undergoes iterative branching to generate the renal collecting system. This branching morphogenesis is coordinated by reciprocal inductive signals between the ureteric bud epithelium and the surrounding mesenchyme, and defects in these interactions can lead to malformations of the urinary tract. Because the collecting duct is the site of fine-tuning of water and electrolyte homeostasis, its developmental failure has direct physiological consequences. Recent advances in directed differentiation of human pluripotent stem cells into ureteric bud and collecting duct organoids have made it possible to model human collecting duct development and disease in vitro. These organoid systems complement classic embryological studies and provide a platform for genetic and pharmacological interrogation of GO:0072205. This article synthesizes the authoritative definition and current literature on metanephric collecting duct development, highlighting the genes, mechanisms, and research methods that define this process.
metanephric collecting duct development At A Glance
| GO ID | GO:0072205 |
|---|---|
| GO term | metanephric collecting duct development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Progression of the collecting duct in the metanephros from formation to mature structure that responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance |
| Anatomical context | Metanephros; collecting duct is the final common path for urine before the ureter and bladder |
| Developmental origin | Ureteric bud branching within the metanephric mesenchyme |
| Related disease | Congenital anomalies of the kidney and urinary tract, including ureteropelvic junction obstruction |
| Model system | Human pluripotent stem cell-derived ureteric bud and collecting duct organoids |
What Is GO:0072205?
GO:0072205 metanephric collecting duct development is the biological process whose specific outcome is the progression of a collecting duct in the metanephros over time, from its formation to the mature structure. The mature collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte, and acid-base balance, and it is the final common path through which urine flows before entering the ureter and then emptying into the bladder. This term therefore covers the morphogenetic, cellular, and functional maturation events that convert the ureteric bud-derived collecting duct precursor into a hormone-responsive, urine-concentrating epithelium.
Why Is metanephric collecting duct development Important in Cell Biology?
Metanephric collecting duct development is essential because the collecting duct is the final site of urine concentration and acid-base regulation, and its developmental failure underlies a spectrum of congenital and acquired kidney disorders. Understanding GO:0072205 informs kidney developmental biology, disease modeling, and regenerative medicine efforts to build functional kidney tissue from stem cells.
• The collecting duct is the final common path for urine before the ureter and bladder, making its development critical for urinary flow.
• Mature collecting duct cells respond to vasopressin and aldosterone to regulate water, electrolyte, and acid-base balance.
• Ureteric bud branching and collecting duct morphogenesis are fundamental to establishing the renal collecting system.
• Defects in collecting duct development contribute to congenital anomalies of the kidney and urinary tract, such as ureteropelvic junction obstruction.
• Human pluripotent stem cell-derived organoids enable modeling of collecting duct development and disease.
• Kidney organoids and tubuloids provide platforms for studying tubular physiology and pathology.
• p53 regulates metanephric development, linking stress-response pathways to collecting duct formation.
• Developmental hypoxia enhances kidney organoid complexity and maturity, highlighting environmental influences on collecting duct development.
• Epithelial nephrogenesis studies provide a framework for understanding how collecting duct cells polarize and differentiate.
• Collecting duct morphogenesis is a classic model for branching morphogenesis and epithelial tube formation.
What Happens During metanephric collecting duct development?
Ureteric bud induction and branching
In simple terms: The collecting duct starts as a bud that grows and splits repeatedly to form the kidney's drainage system.
During metanephric development, the ureteric bud emerges from the nephric duct and invades the metanephric mesenchyme, where reciprocal inductive signals trigger iterative branching. This branching generates the collecting duct system, and its pattern determines the final architecture of the renal collecting system. Classic studies of collecting duct morphogenesis have defined the cellular behaviors that accompany ureteric bud branching and elongation.
Elongation and patterning of the collecting duct
In simple terms: The newly formed branches lengthen and acquire distinct segments that will become the collecting ducts.
Following branching, the ureteric bud-derived epithelium elongates and patterns into the collecting duct system, with regional specialization along the cortico-medullary axis. Epithelial nephrogenesis studies have described how these cells establish polarity and form a continuous lumen. The precise patterning of the collecting duct is essential for its later ability to respond to vasopressin and aldosterone.
Cellular differentiation of collecting duct epithelium
In simple terms: Immature cells become specialized collecting duct cells that can fine-tune water and salt balance.
As the collecting duct matures, its epithelium differentiates into principal and intercalated cell types that mediate water, electrolyte, and acid-base transport. This differentiation is accompanied by the expression of hormone receptors and transporters required for vasopressin and aldosterone responsiveness. Human pluripotent stem cell-derived ureteric bud and collecting duct organoids recapitulate key aspects of this differentiation program in vitro.
Functional maturation and hormone responsiveness
In simple terms: The mature collecting duct becomes able to respond to hormones that control urine concentration.
The final stage of metanephric collecting duct development is functional maturation, in which the duct acquires the capacity to respond to vasopressin and aldosterone to regulate water, electrolyte, and acid-base balance. This maturation is critical for the kidney's ability to produce concentrated urine and maintain homeostasis. Organoid and tubuloid models are increasingly used to study the functional maturation of collecting duct cells.
Key Genes Involved in GO:0072205 metanephric collecting duct development
The following genes and proteins have been implicated in metanephric collecting duct development and related kidney developmental processes based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Regulates metanephric development, including collecting duct formation | p53 knockout and point-mutation models to study developmental roles |
| GDNF | Secreted factor involved in ureteric bud induction and branching | Knockout and overexpression models for branching morphogenesis |
| RET | Receptor tyrosine kinase mediating ureteric bud outgrowth | Point mutations linked to congenital kidney anomalies |
| WNT9B | Signaling molecule in ureteric bud and collecting duct development | Knockout models to assess collecting duct induction |
| WNT11 | Regulates ureteric bud branching morphogenesis | Overexpression and knockout studies in organoid systems |
| PAX2 | Transcription factor required for ureteric bud and collecting duct development | Knockout models for renal malformations |
| PAX8 | Transcription factor in kidney and collecting duct development | Knockout and knock-in models for lineage tracing |
| HNF1B | Transcription factor regulating collecting duct differentiation | Point mutations associated with renal cysts and diabetes |
| EMX2 | Transcription factor involved in ureteric bud branching | Knockout models for collecting duct patterning |
| BMP4 | Signaling molecule modulating ureteric bud branching | Overexpression and knockout studies in kidney organoids |
| FGF8 | Growth factor influencing ureteric bud outgrowth | Knockout models for branching defects |
| SIX1 | Transcription factor in metanephric development | Knockout models for kidney agenesis and hypoplasia |
| SALL1 | Transcription factor required for ureteric bud branching | Knockout models for renal dysplasia |
| AQP2 | Water channel mediating vasopressin response in collecting duct | Knock-in and overexpression models for water transport |
| AVPR2 | Vasopressin receptor mediating water reabsorption | Point mutations linked to nephrogenic diabetes insipidus |
| NR3C2 | Mineralocorticoid receptor mediating aldosterone response | Knockout and point-mutation models for electrolyte balance |
| UMOD | Uromodulin expressed in collecting duct, involved in urine concentration | Knockout models for tubulointerstitial disease |
How Is metanephric collecting duct development Regulated?
Metanephric collecting duct development is regulated by a network of transcriptional and signaling pathways, including p53, which regulates metanephric development. Developmental hypoxia has been shown to enhance kidney organoid complexity and maturity, indicating that oxygen tension modulates collecting duct development. Reciprocal inductive signals between the ureteric bud and metanephric mesenchyme, such as GDNF/RET and WNT pathways, control branching and differentiation. Hormonal regulation by vasopressin and aldosterone acts on the mature collecting duct to regulate water, electrolyte, and acid-base balance.
metanephric collecting duct development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HNF1B | Renal cysts and diabetes syndrome; collecting duct malformation | Knockout and point-mutation organoids |
| AVPR2 | Nephrogenic diabetes insipidus; vasopressin resistance | Point-mutation knock-in cell models |
| AQP2 | Nephrogenic diabetes insipidus; impaired water reabsorption | Knockout and overexpression models |
| UMOD | Tubulointerstitial kidney disease; uromodulin accumulation | Knockout and knock-in models |
| RET | Congenital anomalies of the kidney and urinary tract | Point-mutation and knockout models |
Congenital anomalies of the kidney and urinary tract
Disrupted metanephric collecting duct development contributes to congenital anomalies of the kidney and urinary tract, including ureteropelvic junction obstruction, which can impair urine flow from the kidney to the bladder. Defects in ureteric bud branching and collecting duct morphogenesis are central to these malformations.
Nephrogenic diabetes insipidus and electrolyte disorders
The mature collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte, and acid-base balance. Developmental or functional defects in this response can lead to disorders of water and electrolyte homeostasis.
Kidney developmental disorders and organoid modeling
Human pluripotent stem cell-derived ureteric bud and collecting duct organoids provide models to study developmental kidney disorders and to test potential therapies. Kidney organoids and tubuloids are also used to investigate tubular pathology and regeneration.
From metanephric collecting duct development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate ureteric bud branching? | Knockout organoid model |
| Does a specific mutation impair collecting duct differentiation? | Point-mutation knock-in cell model |
| Where is a protein expressed during collecting duct development? | Tagged knock-in reporter model |
| Does overexpression of a factor enhance collecting duct maturation? | Overexpression cell model |
| What is the role of p53 in metanephric development? | p53 knockout mouse model |
| How does hypoxia affect collecting duct organoid maturity? | Hypoxia-treated kidney organoid model |
How to Study the metanephric collecting duct development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Organoid differentiation | Formation of ureteric bud and collecting duct structures | Modeling human collecting duct development |
| RNA sequencing | Transcriptional changes during differentiation | Identifying regulators of collecting duct development |
| Proteomics | Protein expression and modifications | Characterizing collecting duct maturation |
| Live imaging | Branching and elongation dynamics | Studying ureteric bud morphogenesis |
| Lineage tracing | Cell fate and origin | Tracking collecting duct cell lineages |
| Transport assays | Water and electrolyte flux | Assessing functional maturation |
| Hypoxia treatment | Organoid complexity and maturity | Studying environmental effects on development |
| p53 knockout | Metanephric developmental defects | Investigating p53 in kidney development |
Organoid and tubuloid culture
Directed differentiation of human pluripotent stem cells into ureteric bud and collecting duct organoids enables the study of collecting duct development in vitro. Kidney organoids and tubuloids provide complementary systems for modeling tubular physiology and disease.
Transcriptomic and proteomic profiling
RNA sequencing and proteomics can be used to characterize gene expression changes during collecting duct differentiation and maturation. These approaches help identify markers and regulators of metanephric collecting duct development.
Imaging and lineage tracing
Live imaging and lineage tracing in organoids and animal models reveal the cellular dynamics of ureteric bud branching and collecting duct elongation. Tagged knock-in reporters allow visualization of specific cell types during development.
Functional transport assays
Transport assays in collecting duct cells measure water, electrolyte, and acid-base flux in response to vasopressin and aldosterone. These assays are used to assess the functional maturation of collecting duct epithelium.
How CRISPR Can Be Used to Study GO:0072205 metanephric collecting duct development
Knockout
CRISPR knockout of candidate genes in human pluripotent stem cell-derived organoids can reveal their requirement for ureteric bud branching and collecting duct differentiation. For example, knockout of transcription factors such as HNF1B or PAX2 can be used to model congenital kidney anomalies.
Point Mutation
Point mutations identified in patients with collecting duct-related disorders, such as AVPR2 or AQP2 variants, can be introduced into cell models to study their functional impact on vasopressin responsiveness. These models help distinguish pathogenic from benign variants.
Knock-in
Knock-in of reporter tags or disease-associated alleles allows visualization and functional analysis of collecting duct cells during development. Tagged knock-in models are valuable for lineage tracing and protein localization studies.
Overexpression
Overexpression of signaling factors such as WNT11 or GDNF can be used to test sufficiency for inducing or enhancing collecting duct development in organoid systems. Overexpression models complement loss-of-function studies to establish causality.
How EDITGENE Supports metanephric collecting duct development Research
Researchers studying metanephric collecting duct development-related genes often need to determine whether a candidate gene is causally involved in ureteric bud branching, collecting duct differentiation, or functional maturation. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and organoid models for such studies.
Contact EDITGENE today to design your custom CRISPR model for metanephric collecting duct development research.
Frequently Asked Questions About metanephric collecting duct development
What is GO:0072205 metanephric collecting duct development?
GO:0072205 is the biological process describing the progression of a collecting duct in the metanephros from its formation to the mature structure that responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance.
What genes are involved in metanephric collecting duct development?
Genes such as TP53, GDNF, RET, WNT9B, WNT11, PAX2, PAX8, HNF1B, and AQP2 have been implicated in metanephric development and collecting duct formation.
Why is the collecting duct important for kidney function?
The collecting duct is the final common path for urine before it enters the ureter and bladder, and it responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance.
How is metanephric collecting duct development studied?
It is studied using animal models, human pluripotent stem cell-derived ureteric bud and collecting duct organoids, and kidney tubuloids.
What diseases are linked to defective collecting duct development?
Defects are linked to congenital anomalies of the kidney and urinary tract, including ureteropelvic junction obstruction, and to disorders of water and electrolyte balance.
What is the role of p53 in metanephric development?
p53 regulates metanephric development, and its loss can affect kidney developmental processes including collecting duct formation.
Can organoids model collecting duct development?
Yes, directed differentiation of human pluripotent stem cells into ureteric bud and collecting duct organoids recapitulates key aspects of collecting duct development.
How does hypoxia affect kidney organoid maturity?
Developmental hypoxia has been shown to enhance kidney organoid complexity and maturity, including collecting duct structures.
What is the ureteric bud's role in collecting duct formation?
The ureteric bud invades the metanephric mesenchyme and undergoes branching to generate the collecting duct system.
What experimental models are used to study collecting duct development?
Models include knockout and point-mutation cell lines, knock-in reporters, overexpression systems, and organoid cultures.
Conclusion
GO:0072205 metanephric collecting duct development defines the formation and maturation of the collecting duct, the final common pathway for urine and a key regulator of water, electrolyte, and acid-base balance. Research using animal models and human stem cell-derived organoids has elucidated the signaling and transcriptional networks that control ureteric bud branching and collecting duct differentiation. Understanding this process is essential for deciphering congenital kidney anomalies and for developing regenerative strategies. Continued advances in organoid technology and CRISPR-based modeling will further clarify the mechanisms of metanephric collecting duct development and its role in disease.
References
- 1. Shi M et al.. 2023. Directed differentiation of ureteric bud and collecting duct organoids from human pluripotent stem cells.. Nat Protoc 18(8):2485-2508 PMID: 37460630
- 2. Davies JA et al.. 1999. Collecting duct morphogenesis.. Pediatr Nephrol 13(6):535-41 PMID: 10452285
- 3. Smyth IM. 2021. Development of the metanephric kidney.. Curr Top Dev Biol 143:111-150 PMID: 33820620
- 4. Yousef Yengej FA et al.. 2020. Kidney Organoids and Tubuloids.. Cells 9(6) PMID: 32466429
- 5. Kumar G et al.. 2026. Ureteropelvic Junction Obstruction.. PMID: 32809575
- 6. Horster M et al.. 1997. Epithelial nephrogenesis.. Pflugers Arch 434(6):647-60 PMID: 9305995
- 7. Lim H et al.. 2025. Developmental Hypoxia Enhances Kidney Organoid Complexity and Maturity.. Adv Sci (Weinh) 12(40):e01661 PMID: 40841925
- 8. Saifudeen Z et al.. 2009. p53 regulates metanephric development.. J Am Soc Nephrol 20(11):2328-37 PMID: 19729440
